EP2281327B1 - Interconnecteur de derivation modulaire - Google Patents

Interconnecteur de derivation modulaire Download PDF

Info

Publication number
EP2281327B1
EP2281327B1 EP09734112A EP09734112A EP2281327B1 EP 2281327 B1 EP2281327 B1 EP 2281327B1 EP 09734112 A EP09734112 A EP 09734112A EP 09734112 A EP09734112 A EP 09734112A EP 2281327 B1 EP2281327 B1 EP 2281327B1
Authority
EP
European Patent Office
Prior art keywords
interconnector
lead
receptacles
electrical connection
wire filars
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP09734112A
Other languages
German (de)
English (en)
Other versions
EP2281327A1 (fr
Inventor
Gerald G. Lindner
Paulette C. Olson
Darren A. Janzig
Chris J. Paidosh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medtronic Inc
Original Assignee
Medtronic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medtronic Inc filed Critical Medtronic Inc
Publication of EP2281327A1 publication Critical patent/EP2281327A1/fr
Application granted granted Critical
Publication of EP2281327B1 publication Critical patent/EP2281327B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01R—ELECTRICALLY-CONDUCTIVE CONNECTIONS; STRUCTURAL ASSOCIATIONS OF A PLURALITY OF MUTUALLY-INSULATED ELECTRICAL CONNECTING ELEMENTS; COUPLING DEVICES; CURRENT COLLECTORS
    • H01R31/00—Coupling parts supported only by co-operation with counterpart
    • H01R31/06—Intermediate parts for linking two coupling parts, e.g. adapter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0551—Spinal or peripheral nerve electrodes
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01R—ELECTRICALLY-CONDUCTIVE CONNECTIONS; STRUCTURAL ASSOCIATIONS OF A PLURALITY OF MUTUALLY-INSULATED ELECTRICAL CONNECTING ELEMENTS; COUPLING DEVICES; CURRENT COLLECTORS
    • H01R2201/00—Connectors or connections adapted for particular applications
    • H01R2201/12—Connectors or connections adapted for particular applications for medicine and surgery
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T29/00—Metal working
    • Y10T29/49—Method of mechanical manufacture
    • Y10T29/49002—Electrical device making
    • Y10T29/49117—Conductor or circuit manufacturing

Definitions

  • This application relates to medical devices, more particularly implantable leads and lead extensions for delivering electrical signals.
  • Implantable electrical signal generators such as pacemakers, defibrillators, neurostimulators, and the like, have been used to treat a variety of diseases. Such devices generate electrical signals that are transferred to a patient's tissue through electrodes present on a distal end portion of a lead.
  • the proximal end portion of a lead, connected to a signal generator typically contains a number of connector rings corresponding to the number of electrodes.
  • Conductors also referred to as wire filars or merely filars, run within and along the lead body and electrically couple the connectors to the electrodes.
  • implantable device is an implantable neurological stimulation system that can be used to treat conditions such as pain, movement disorders, pelvic floor disorders, gastroparesis, and a wide variety of other medical conditions.
  • the neurostimulation system typically includes a neurostimulator, a stimulation lead, and an optional lead extension.
  • the neurostimulator system can be an Itrel II TM Model 7424 or an Itrel 3 TM Model 7425 available from Medtronic, Inc., in Minneapolis, Minn., that can be used to treat conditions such as pain, movement disorders and pelvic floor disorders.
  • the neurostimulator is typically connected to a stimulation lead that has one or more electrodes to deliver electrical stimulation to a specific location in the patient's body.
  • a device according to the preamble of claim 1 is known from US2004230268 .
  • the invention is defined in claims 1 and 11.
  • the present disclosure is directed to implantable leads and lead extensions and methods of making the leads and extensions.
  • a lead end interconnector module is present at at least one end of the lead or extension.
  • an implantable medical device such as a lead or lead extension, having a body
  • the body includes an external surface, a proximal end portion configured to be at least partially received by an apparatus, and distal end portion configured to be attached to an electrode tip.
  • the implantable medical device further includes a conductive member at the distal end portion of the body and an electrical contact at the proximal end portion of the body. The electrical contact is electrically coupled to the conductive member and is positioned such that, when received by the apparatus, at least a portion of the apparatus is capable of electrically coupling to the electrical contact.
  • the invention provides an end interconnector for attachment to a lead body of an electrical lead for an implantable medical device, the end interconnector configured to engage with one of the proximal end or the distal end of the lead body.
  • the interconnector has a body having a surface, a first end and a second end, the body first end having a longitudinally spiralled receptacle for each of a plurality of wire filars from the lead body, and the body second end having a receiver for each of a plurality of connection wires extending to the medical device.
  • the interconnector includes an electrical connection region configured to provide electrical connection between the plurality of wire filars and the plurality of connection wires.
  • the interconnector may have a plurality of longitudinal receptacles for receiving the plurality of wire filars; these receptacles may be present within the surface of the interconnector body. In other embodiments, the receptacles are passages in the interconnector body.
  • the invention provides an electrical lead for an implantable medical device, the lead comprising a lead body having a proximal end and a distal end and a plurality of electrically conductive wire filars extending from the proximal end to the distal end.
  • An end interconnector is electrically engaged with the wire filars at one or both ends of the lead body.
  • Electrically engaged to the interconnector at the lead's distal end may be a medical device, such as an electrode tip.
  • Electrical leads may be provided to the user (e.g., a doctor or surgeon) with the end interconnector engaged with the medical device, or, the user may attach the desired medical device to the interconnector.
  • the invention provides a method of assembling an electrical lead.
  • the method includes providing a lead body having a plurality of wire filars extending from a distal end to a proximal end, placing the wire filars from either the distal end or the proximal end of the lead body into the receptacles at the first end of the interconnector, and electrically connecting the wire filars to the electrical connection region.
  • the method may include attaching a second interconnector to the other end of the lead body. These methods may be done at the manufacturing facility of the lead. Further methods include attaching a medical device, such as an electrode tip, to an end of the lead; these methods may be done at the manufacturing facility or at the point of use.
  • FIG. 1 is a diagrammatic representation of a general environmental view for a neurostimulation system embodiment.
  • FIG. 2 is a perspective view of the neurostimulation system embodiment of FIG. 1 .
  • FIG. 3 is a perspective view of an exemplary embodiment of a lead end interconnector module according to this disclosure.
  • FIG. 4 is a perspective view of the lead end interconnector module of FIG. 3 electrically connected to a lead body.
  • FIG. 5 is a side view of an exemplary embodiment of a lead end interconnector module according to this disclosure.
  • FIG. 6 is a perspective view of the lead end interconnector module of FIG. 5 electrically connected to a lead body.
  • FIG. 7 is an exploded perspective view of an exemplary embodiment of a lead end interconnector module according to this disclosure, including a transition member positioned between the interconnector and the lead body.
  • FIG. 8 is a perspective view of an electrode tip positioned for electrical connection with the lead end interconnector module of FIG. 7 .
  • proximal and distal refer to positions relative to an implantable pulse or signal generator.
  • a proximal portion or end of a lead is a portion or end nearer a signal generator (e.g., a neurostimulator), and a distal portion or end is a portion or end further from the signal generator.
  • a signal generator e.g., a neurostimulator
  • a lead end interconnector module is present at at least one end of the lead or extension.
  • the lead end interconnector module facilitates the manufacture of leads and their connection to a signal generator and/or a medical device such as an electrode tip.
  • FIG. 1 shows a general environmental view 10 for an implantable neurostimulation system.
  • Neurostimulation systems are used to treat conditions such as pain, movement disorders, pelvic floor disorders, gastroparesis, and a wide variety of other medical conditions.
  • Neurostimulation system 20 includes a neurostimulator 22, a stimulation lead extension 30, and a stimulation lead 40.
  • Neurostimulator 22 is typically implanted subcutaneously in a patient's body 28 at a location selected by the clinician; although FIG. 1 illustrates neurostimulator 22 implanted in the patient's abdomen, other locations are suitable.
  • Stimulation lead 40 is typically fixed in place terminating near the desired location selected by the clinician (e.g., in the brain or spinal cord) using a device such as an adjustable anchor.
  • FIG. 2 shows an enlarged view of implantable neurostimulation system 20 having implantable neurostimulator 22, stimulation lead 40, and lead extension 30.
  • Implantable neurostimulator 22 has a housing 24, a power supply (e.g., a battery) within housing 24, and stimulation electronics coupled to the power supply and coupled to a connector block 26, which is also known as a terminal block.
  • Stimulation lead 40 has a lead proximal end 42, a lead distal end 44 and a lead body 45.
  • At lead distal end 44 is medical device such as an electrode tip having at least one stimulation electrode (not illustrated).
  • Lead extension 30 has an extension proximal end 32, an extension distal end 34, and an extension body 35.
  • Lead proximal end 42 connects to lead extension distal end 34 at connector 50; either or both lead proximal end 42 or extension distal end 34 may include an electrode tip that engages with connector 50.
  • Lead 40 and lead extension 30 provide electrical communication from neurostimulator 22 to the electrode tip at distal end 44.
  • Lead distal end 44 contains at least one electrode but in most embodiments has a plurality of such electrodes (e.g., 4, 8, 16, etc.).
  • Extending through lead 40 and lead extension 30 are electrically conducting wire, often referred to as filars or wire filars, that couple neurostimulator 22 to the electrode tip and its electrode(s).
  • the wire filars may, for example, be stranded (made up of many small wires), braided-stranded or "BSW" (braided of many small wires), or solid or monofilament. Extending over and covering the wire filars is an electrically insulating jacket or sheath.
  • this jacket is a polymeric material, such as ethylene tetrafluoroethylene (ETFE), polytetrafluoroethylene (PTFE), silicone rubber or polyurethane. Other materials that act as electrical insulators can be used.
  • a shielding layer or jacket may be present, optionally over the insulating jacket. An example of one suitable shielding layer is described in U.S. Patent Application Publication No. 2005/0222658 .
  • the invention of this disclosure is directed to an end piece interconnector for a lead structure, for either or both proximal end 42 or distal end 44 of lead 40, or proximal end 32 or distal end 34 of lead extension 30.
  • proximal end 42 or distal end 44 of lead 40 or proximal end 32 or distal end 34 of lead extension 30.
  • proximal end 32 or distal end 34 of lead extension 30 or proximal end 32 or distal end 34 of lead extension 30.
  • Interconnector 100 has a body 105, usually made from a nonconductive or insulative material (e.g., a polymeric material (preferably medical grade polymeric material) such as polyurethane, polyethylene, polysulfone, polyetheretherketone, silicone rubber, or combinations thereof) having a first end 102 and an opposing second end 104.
  • First end 102 is configured to connect with a lead body (e.g., lead body 45) and second end 104 is configured to connect with a medical device, such as an electrode tip.
  • a lead body e.g., lead body 45
  • second end 104 is configured to connect with a medical device, such as an electrode tip.
  • Interconnector 100 includes a lead end region 112 proximate first end 102 and an extension region 114 proximate second end 104.
  • Lead end region 112 has an outer surface 113.
  • Present between lead end region 112 and extension region 114 is an electrical connection region 115.
  • receptacles 120 Present in lead end region 112 are a plurality of receptacles 120, at least one for each wire filar of the lead body to which interconnector 100 is to be connected.
  • Receptacles 120 are configured to direct the wire filars to electrical connection region 115.
  • receptacles 120 are channels within surface 113 of lead end region 112, in particular, eight channels are molded or otherwise formed in end region 112.
  • Receptacles 120 spiral around lead end region 112, extending longitudinally from first end 102 to electrical connection region 115.
  • Electrical connection region 115 includes junction areas 150, at least one for each wire filar of the lead body to which interconnector 100 is to be connected, and typically the same number of junction areas 150 as receptacles 120.
  • Junction areas 150 are in electrical connection with extension region 114, which includes a plurality of receivers 140, at least one for each wire filar of the lead body to which interconnector 100 is to be connected, and typically the same number of receivers 140 as receptacles 120.
  • interconnector 100 has eight receivers 140.
  • Either or both receivers 140 and junction areas 150 may be of a conductive material, such as, but not limited to, titanium, stainless steel, tantalum, palladium, a cobalt-nickel-chromium alloy, a platinum-iridium alloy, or a palladium alloy. Either or both receivers 140 and junction areas 150 may include a weldable or solderable material.
  • Electrode wires 550 provide electrical connection to a medical device, such as an electrode tip, and in some embodiments, are considered as part of the medical device, e.g., electrode tip.
  • Connection wires 550 may be removably connected to receivers 140.
  • eight electrode connection wires 550 are illustrated.
  • the number of connection wires 550 is the same as the number of wire filars of the lead body to which interconnector 100 is to be connected.
  • FIG. 4 illustrates interconnector 100 connected to a lead body.
  • Lead body 450 has a plurality of electrically conductive wire filars 460 extending longitudinally through lead body 450 and covered by an insulative jacket 470.
  • eight wire filars 460 are illustrated as a helical extension.
  • Each of the eight wire filars 460 has a corresponding receptacle 120, contact area 150 and receiver 140, and corresponding electrode wire 550 for connecting to a medical device.
  • wire filar 461 is present in receptacle 121 and terminates at contact area 151. Electrically connected to contact area 151 is connection pad 141, from which extends electrode wire 161.
  • each wire filar 460 is inserted into a corresponding receptacle 120 and channeled to junction area 150 in connecting region 115.
  • Wire filar 460 is secured within junction area 150 and electrical connection is made; this may be done, for example, by welding (e.g., ultrasonic welding) or soldering, by crimping, staking, or by a quick-connect or snap fit or other suitable mechanism.
  • welding e.g., ultrasonic welding
  • soldering crimping, staking, or by a quick-connect or snap fit or other suitable mechanism.
  • Electrode wire 550 is secured to receivers 140 and electrical connection is made; this may be done, for example, by welding or soldering, by crimping, staking, or by a quick-connect or snap fit.
  • FIGS. 5 and 6 An exemplary embodiment of an end interconnector having longitudinally spiraled surface receptacles is illustrated in FIGS. 5 and 6 as end interconnector 200.
  • the various features of interconnector 200 are the same as or similar to interconnector 100 of FIGS. 3 and 4 , unless otherwise specified.
  • End interconnector 200 has a body 205 having a first end 202 and an opposing second end 204.
  • Interconnector 200 includes a lead end region 212 proximate first end 202 and an extension region 214 proximate second end 204.
  • Present between lead end region 212 and extension region 214 is electrical connection region 215.
  • Lead end region 212 has a guide portion 212A and an engagement portion 212B having a surface 213.
  • Present in engagement portion 212B are a plurality of receptacles 220, at least one for each wire filar of the lead body to which interconnector 200 is to be connected.
  • Receptacles 220 are configured to direct the wire filars to electrical connection region 215 and junction areas 250.
  • Guide portion 212A extends from engagement portion 212B and facilitates engagement of interconnector 200 with the wire filars during assembly of interconnector 200 with the engaging lead body by providing an alignment structure, e.g., a centering structure.
  • Guide portion 212A of interconnector 200 is a conical structure, having a tapered surface.
  • interconnector 200 is illustrated connected to wire filars 460 of a lead body.
  • the plurality of spiraling electrically conductive wire filars 460 wrap around guide portion 212A and engagement portion 212B.
  • Guide portion 212A is encased by wire filars 460 and typically by the sheath (not illustrated) of the lead body.
  • an optional retainment system 270 is shown on interconnector 200, to better hold wire filars 460 in receptacles 220 and in electrical connection region 215.
  • Retainment system 270 may be temporarily positioned on interconnector 200, for example, to maintain wire filars 460 in receptacles 220 until permanently positioned (e.g., welded or soldered).
  • retainment system 270 is a ring-type structure extending around lead end region 212.
  • end interconnector 300 An exemplary embodiment of an end interconnector, this one having longitudinally extending enclosed receptacles, is illustrated in FIG. 7 as end interconnector 300.
  • the various features of interconnector 300 are the same or similar to interconnector 100 of FIGS. 3 and 4 and interconnector 200 of FIGS. 5 and 6 , unless otherwise specified.
  • End interconnector 300 has a body 305 having a first end 302 and an opposing second end 304.
  • Interconnector 300 includes a lead end region 312 proximate first end 302 and an extension region 314 proximate second end 304.
  • Present between lead end region 312 and extension region 314 is an electrical connection region 315.
  • Extending through body 305, from lead end region 312 through electrical connection region 315 to extension region 314 are a plurality of receptacles 320, at least one for each wire filar of the lead body to which interconnector 300 is to be connected.
  • Receptacles 320 are configured to direct the wire filars to junction areas 350 or electrical connection region 315.
  • receptacles 320 extend through lead end region 312 to junction areas 350. That is, receptacles 320 are not on an outer surface of lead end region 312 as in the previous embodiments of interconnectors 100, 200, but pass through an inner portion of lead end region 312. Receptacles 320 extend the length of interconnector 300, from first end 302 to second end 304. At second end 304, receptacles 320 are configured to accept electrode connector wires 550 from an electrode tip or other medical device.
  • junction areas 150, 250 of electrical connection regions 115, 215 are exposed; that is, junction areas 150, 250 are present on an outer surface of interconnector 100, 200.
  • the electrical junction areas 350 where wire filars from a lead body and electrode connector wires from a medical device such as an electrode tip make electrical connection, are within tubular receptacles 320.
  • Receptacles 320 and/or junction areas 350 may be of a conductive material, such as, but not limited to, titanium, stainless steel, tantalum, palladium, a cobalt-nickel-chromium alloy, a platinum-iridium alloy, or a palladium alloy.
  • Either or both receptacles 320 and/or junction areas 350 may be of a weldable or solderable material.
  • the junction areas 350 are part of or integral with receptacles 320.
  • Interconnector 300 includes an optional transition member to facilitate the engagement of wire filars 460 with receptacles 320.
  • transition member 400 positioned adjacent first end 302 is transition member 400.
  • Transition member 400 has a body 405 having a first end 402 and an opposite second end 404.
  • second end 404 engages with first end 302 of interconnector 300, and may be permanently affixed thereto.
  • Extending through body 405 is a plurality of receptacles 420.
  • receptacles 420 pass longitudinally through body 405 from first end 402 to second end 404 at an angle (e.g., at an angle of about 20 degrees); that is, receptacles 420 do not pass through parallel to the longitudinal axis of body 405.
  • Transition member 400 provides a transition for wire filars 460 of lead body 450 to interconnector 300.
  • wire filars 460 spiral longitudinally at an angle of about 45 degrees, and in interconnector 300, electrical connection region 315 holds the wire filars parallel to its longitudinal axis. Transition member 400 cases the progression from 45 degrees to 0 degrees for wire filars 460.
  • interconnector 300 and transition member 400 are illustrated in preparation for connection to lead body 450 and a plurality of electrode connection wires 550.
  • Electrode wires 550 provide electrical connection to the electrode tip and in some embodiments, as illustrated in FIG. 8 .
  • transition member 400 is attached to first end 302 of interconnector 300.
  • Each wire filar 460 is inserted into a corresponding receptacle 420 and fed through to junction area 350.
  • a wire filar 460 may be fed into receptacle 420 prior to attaching transition member 400 to interconnect 300.
  • Wire filar 460 is secured within junction area 350 and electrical connection is made; this may be done, for example by welding or soldering.
  • Electrode tip 500 is illustrated in FIG. 8 , poised for connection to interconnector 300. Electrode tip 500 has eight electrode areas 510, one for each electrode wire 550 extending from tip 500. To connect electrode tip 500 to interconnector 300, each electrode wire 550 is inserted into a corresponding receptacle 320 and fed through to junction area 350. Electrode wire 550 is secured within junction area 350 and electrical connection is made; this may be done, for example by welding or soldering.
  • the various embodiments of the MODULAR LEAD INTERCONNECTOR described above can be used at one or both ends of a lead body.
  • the interconnectors may additionally or alternately be used for lead extensions.
  • the interconnector may be configured for different numbers of wire filars and electrode wires, for example, 4, 6, 12, 16, 32, etc.
  • the interconnector may be used with other lead body configurations, having, for example, different filar numbers or configurations, or, for example, various jackets or sheaths.
  • the medical device may be, for example, an electrode tip other than illustrated.

Landscapes

  • Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Electrotherapy Devices (AREA)

Claims (15)

  1. Interconnecteur d'extrémité en vue d'une fixation à un corps de dérivation d'une dérivation électrique pour un dispositif médical implantable, l'interconnecteur d'extrémité étant configuré pour être mis en prise avec l'une de l'extrémité proximale ou de l'extrémité distale du corps de dérivation, l'interconnecteur comportant :
    (a) un corps (105) ayant une surface (113), une première extrémité (102) et une seconde extrémité (104), la première extrémité du corps ayant un réceptacle respectif (120) pour chaque fil parmi une pluralité de fils (460) du corps de dérivation et la seconde extrémité du corps ayant un récepteur respectif (140) pour chaque fil de connexion parmi une pluralité de fils de connexion (550) qui s'étendent longitudinalement à travers le dispositif médical et à partir de celui-ci ; et
    (b) une région de connexion électrique (115), configurée pour fournir une connexion électrique entre la pluralité de fils dans les réceptacles et la pluralité de fils de connexion dans les récepteurs,
    caractérisé en ce que ledit réceptacle et lesdits fils sont spiralés longitudinalement.
  2. Interconnecteur d'extrémité selon la revendication 1, dans lequel les réceptacles spiralés longitudinalement sont des canaux spiralés longitudinalement dans la surface du corps d'interconnecteur.
  3. Interconnecteur d'extrémité selon la revendication 1, dans lequel les réceptacles spiralés longitudinalement sont des passages spiralés longitudinalement dans le corps d'interconnecteur.
  4. Interconnecteur d'extrémité selon la revendication 3, dans lequel les passages spiralés longitudinalement comportent un matériau électriquement conducteur.
  5. Interconnecteur d'extrémité selon l'une quelconque des revendications 1 à 4, dans lequel l'interconnecteur d'extrémité comporte un élément de transition (400) et un plot de connexion, et dans lequel l'élément de transition comporte les réceptacles spiralés longitudinalement.
  6. Interconnecteur d'extrémité selon la revendication 5, dans lequel le plot de connexion comporte la région de connexion électrique.
  7. Interconnecteur d'extrémité selon la revendication 6, dans lequel la région de connexion électrique dans le plot de connexion comporte des passages droits.
  8. Dérivation électrique pour un dispositif médical implantable, la dérivation comportant :
    (a) un corps de dérivation (45) comportant :
    (i) une extrémité proximale (42) et une extrémité distale (44) ;
    (ii) une pluralité de fils spiralés longitudinalement électriquement conducteurs (460) s'étendant depuis l'extrémité proximale jusqu'à l'extrémité distale ;
    (b) un interconnecteur d'extrémité (100) selon l'une quelconque des revendications 1 à 7, électriquement mis en prise avec l'une de l'extrémité proximale ou de l'extrémité distale du corps de dérivation.
  9. Dérivation électrique selon la revendication 8, comportant un premier interconnecteur d'extrémité électriquement mis en prise avec l'extrémité proximale du corps de dérivation et un second interconnecteur d'extrémité électriquement mis en prise avec l'extrémité distale du corps de dérivation.
  10. Dérivation électrique selon l'une quelconque des revendications 8 et 9 comportant en outre une pointe d'électrode (500) électriquement connectée à l'extrémité proximale de la dérivation, et/ou à l'extrémité distale de la dérivation.
  11. Procédé d'assemblage de la dérivation électrique selon la revendication 8, comportant les étapes consistant à :
    agencer un corps de dérivation (45) ayant une pluralité de fils spiralés longitudinalement (460) s'étendant depuis une extrémité distale jusqu'à une extrémité proximale ;
    placer les fils à partir de l'extrémité distale ou de l'extrémité proximale du corps de dérivation dans les réceptacles spiralés longitudinalement (120) au niveau de la première extrémité de l'interconnecteur (100) ; et
    connecter électriquement les fils à la région de connexion électrique.
  12. Procédé selon la revendication 11, comportant les étapes consistant à :
    placer les fils de l'extrémité distale du corps de dérivation dans les réceptacles au niveau de la première extrémité de l'interconnecteur ; et
    placer les fils de l'extrémité proximale du corps de dérivation dans les réceptacles au niveau de la première extrémité d'un second interconnecteur.
  13. Procédé selon la revendication 11, dans lequel la connexion électrique des fils à la région de connexion électrique comporte l'étape consistant à :
    connecter les fils à la région de connexion électrique par soudage, brasage, sertissage, agrafage, ultrasons, une prise de courant ou un assemblage par pression.
  14. Procédé selon la revendication 13, dans lequel la connexion électrique des fils à la région de connexion électrique comporte l'étape consistant à :
    souder les fils à la région de connexion électrique.
  15. Procédé selon la revendication 11, comportant en outre les étapes consistant à :
    placer des fils de connexion d'électrode depuis une pointe d'électrode dans les récepteurs au niveau de la seconde extrémité de l'interconnecteur ; et
    connecter électriquement les fils de connexion d'électrode à la région de connexion électrique.
EP09734112A 2008-04-21 2009-01-23 Interconnecteur de derivation modulaire Active EP2281327B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4653008P 2008-04-21 2008-04-21
PCT/US2009/031785 WO2009131725A1 (fr) 2008-04-21 2009-01-23 Interconnecteur de dérivation modulaire

Publications (2)

Publication Number Publication Date
EP2281327A1 EP2281327A1 (fr) 2011-02-09
EP2281327B1 true EP2281327B1 (fr) 2012-04-25

Family

ID=40524993

Family Applications (1)

Application Number Title Priority Date Filing Date
EP09734112A Active EP2281327B1 (fr) 2008-04-21 2009-01-23 Interconnecteur de derivation modulaire

Country Status (4)

Country Link
US (1) US8525027B2 (fr)
EP (1) EP2281327B1 (fr)
AT (1) ATE555521T1 (fr)
WO (1) WO2009131725A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3181189A1 (fr) 2015-12-15 2017-06-21 BIOTRONIK SE & Co. KG Conducteur d'électrode implantable et jeu de modules de conducteurs d'électrode

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9054436B2 (en) * 2009-09-30 2015-06-09 Advanced Neuromodulation Systems, Inc. Method of fabricating stimulation lead for applying electrical stimulation to tissue of a patient
US8171621B2 (en) 2009-09-30 2012-05-08 Advanced Neuromodulation Systems, Inc. Methods of fabrication of a simulation lead
US20110077699A1 (en) * 2009-09-30 2011-03-31 John Swanson Medical leads with segmented electrodes and methods of fabrication thereof
US10076657B2 (en) 2011-10-28 2018-09-18 Medtronic, Inc. Lead end having slotted member
US9421362B2 (en) 2011-10-28 2016-08-23 Medtronic, Inc. Modular lead end
US9138576B2 (en) 2011-10-28 2015-09-22 Medtronic, Inc. Lead end having inner support
WO2016048374A1 (fr) 2014-09-26 2016-03-31 Hewlett Packard Enterprise Development Lp Réceptacle de connexion de câble à voies multiples ou à une voie
WO2016133499A1 (fr) 2015-02-18 2016-08-25 Hewlett Packard Enterprise Development Lp Languettes de traction pour l'extraction d'un ensemble câble d'un réceptacle
WO2016137485A1 (fr) * 2015-02-27 2016-09-01 Hewlett Packard Enterprise Development Lp Ensemble câble ayant des ensembles câble à une voie réunis
WO2016175795A1 (fr) 2015-04-29 2016-11-03 Hewlett Packard Enterprise Development Lp Faisceau de câbles
EP3411116B1 (fr) 2016-02-05 2020-01-22 Boston Scientific Neuromodulation Corporation Dérivation de stimulation optique implantable
EP3442651B1 (fr) * 2016-04-15 2022-04-13 Medtronic, Inc. Ensemble de conducteurs pour dispositif médical avec bobine à pas variable
WO2017180827A1 (fr) * 2016-04-15 2017-10-19 Medtronic, Inc. Ensemble de raccordement de fil de dispositif médical
US11110284B2 (en) * 2016-04-15 2021-09-07 Medtronic, Inc. Medical device lead connection assembly with guide hub
US10610680B2 (en) 2016-12-16 2020-04-07 Medtronic, Inc. Modular lead
US11524174B2 (en) 2018-03-23 2022-12-13 Boston Scientific Neuromodulation Corporation Optical stimulation system with on-demand monitoring and methods of making and using
US11565131B2 (en) 2018-03-23 2023-01-31 Boston Scientific Neuromodulation Corporation Optical stimulation systems with calibration and methods of making and using
US11224743B2 (en) 2018-09-21 2022-01-18 Boston Scientific Neuromodulation Corporation Systems and methods for making and using modular leads for electrical stimulation systems
EP3840824A1 (fr) 2018-11-16 2021-06-30 Boston Scientific Neuromodulation Corporation Système de stimulation optique avec surveillance à la demande et procédés de fabrication
US11679256B2 (en) 2019-10-04 2023-06-20 Medtronic, Inc. Method of replacing an implanted neuromodulation device
US11575236B2 (en) 2019-10-04 2023-02-07 Medtronic, Inc. Implantable pulse generator carrier used to interface with multiple lead sizes
US11596789B2 (en) 2019-10-04 2023-03-07 Medtronic, Inc. Adaptor
US11666768B2 (en) 2020-03-04 2023-06-06 Medtronic, Inc. Electrically isolated connector for implantable medical devices
EP4168110A1 (fr) 2020-09-04 2023-04-26 Boston Scientific Neuromodulation Corporation Systèmes de stimulation ayant un agencement de lentilles pour couplage de lumière et procédés de fabrication et d'utilisation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3406247A (en) * 1967-10-09 1968-10-15 Amp Inc Electrical connections for pairs of conductors
US3842191A (en) * 1973-12-17 1974-10-15 Nat Telephone Supply Co Insulated wire splice
JPH02108253U (fr) * 1988-10-07 1990-08-28
US6249708B1 (en) * 1997-08-26 2001-06-19 Angeion Corporation Fluted channel construction for a multi-conductor catheter lead
DE69939068D1 (de) * 1998-11-09 2008-08-21 Medtronic Inc Entfernbare implantierbare medizinische leitung
US6931285B2 (en) * 2001-04-17 2005-08-16 Medtronic, Inc. Drive shaft seal for a medical electrical lead
US7292894B2 (en) * 2002-09-27 2007-11-06 Medtronic, Inc. Methods and apparatus for joining small diameter conductors within medical electrical leads
US7130699B2 (en) * 2003-05-13 2006-10-31 Medtronic, Inc. Medical lead adaptor assembly
US20050027325A1 (en) * 2003-07-31 2005-02-03 Jay Lahti Connector assembly for connecting a lead and an implantable medical device
DE602004005066T2 (de) * 2003-10-02 2007-10-31 Medtronic, Inc., Minneapolis Implantierbare medizinische leitung und herstellungsverfahren
US7519432B2 (en) * 2004-10-21 2009-04-14 Medtronic, Inc. Implantable medical lead with helical reinforcement

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3181189A1 (fr) 2015-12-15 2017-06-21 BIOTRONIK SE & Co. KG Conducteur d'électrode implantable et jeu de modules de conducteurs d'électrode
DE102015121815A1 (de) 2015-12-15 2017-06-22 Biotronik Se & Co. Kg Implantierbare Elektrodenleitung und Satz von Elektrodenleitungs-Modulen

Also Published As

Publication number Publication date
US20110165785A1 (en) 2011-07-07
WO2009131725A1 (fr) 2009-10-29
EP2281327A1 (fr) 2011-02-09
ATE555521T1 (de) 2012-05-15
US8525027B2 (en) 2013-09-03

Similar Documents

Publication Publication Date Title
EP2281327B1 (fr) Interconnecteur de derivation modulaire
US9238132B2 (en) Systems and methods for making and using electrical stimulation systems having multi-lead-element lead bodies
US7184838B2 (en) Implantable medical lead and method of manufacture
US8019439B2 (en) Lead assembly and method of making same
US7974704B2 (en) Lead body constructions for implantable medical electrical leads
US8646172B2 (en) Electrode array assembly and method of making same
AU2009302595B2 (en) Electrical stimulation leads having RF compatibility and methods of use and manufacture
US20150066122A1 (en) Leads with electrodes disposed in mesh material and methods and systems using the leads
AU2010279726B2 (en) Systems and methods for coupling coiled conductors to conductive contacts of an electrical stimulation system
EP3442650B1 (fr) Ensemble de raccordement de fil de dispositif médical ayant un raccord de guidage
US10124161B2 (en) Neurostimulation lead with conductive elements and methods for making the same
CN108883285B (zh) 带有可变螺距线圈的医疗装置引线组件

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20101119

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA RS

RIN1 Information on inventor provided before grant (corrected)

Inventor name: JANZIG, DARREN A.

Inventor name: LINDNER, GERALD G.

Inventor name: OLSON, PAULETTE C.

Inventor name: PAIDOSH, CHRIS J.

17Q First examination report despatched

Effective date: 20110509

DAX Request for extension of the european patent (deleted)
GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 555521

Country of ref document: AT

Kind code of ref document: T

Effective date: 20120515

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602009006609

Country of ref document: DE

Effective date: 20120621

REG Reference to a national code

Ref country code: NL

Ref legal event code: VDEP

Effective date: 20120425

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 555521

Country of ref document: AT

Kind code of ref document: T

Effective date: 20120425

LTIE Lt: invalidation of european patent or patent extension

Effective date: 20120425

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120425

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120425

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120425

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120725

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120825

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120425

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120425

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120425

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120425

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120726

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120827

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120425

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120425

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120425

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120425

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120425

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120425

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120425

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120425

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120425

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120425

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20130128

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120805

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602009006609

Country of ref document: DE

Effective date: 20130128

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120725

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20130131

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20130123

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20130131

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20130131

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20130123

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20130123

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120425

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120425

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20090123

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20130123

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120425

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 8

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 9

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20231219

Year of fee payment: 16

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20231219

Year of fee payment: 16